Bicycle Therapeutics Plc. (BCYC) NASDAQ
$22.36 0.51 (2.33%)
Market Cap: $476.38M
As of 05/15/24 04:00 PM EDT. Market closed.
Bicycle Therapeutics Plc. (BCYC)
NASDAQ
$22.36
0.51 (2.33%)
Market Cap: $476.38M
As of 05/15/24 04:00 PM EDT. Market closed.
bicycle therapeutics is a biotechnology company with big ambitions. we aim to revolutionise the pharmaceutical landscape with our disruptive technology and proprietary bicyclic peptide (bicycle®) product platform and to develop transformational new therapies for patients to improve future treatment options in oncology. bicycles, a new class of small molecular weight drug conjugates for oncology ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Apr 11, 2024 | Sale | $22.49 | 257 | 5,780 | 22,891 | Apr 12, 2024, 04:30 PM |
Lee Kevin | CHIEF EXECUTIVE OFFICER | Apr 03, 2024 | Sale | $23.81 | 3,158 | 75,192 | 387,270 | Apr 05, 2024, 04:30 PM |
Skynner Michael | CHIEF TECHNOLOGY OFFICER | Apr 03, 2024 | Sale | $23.81 | 955 | 22,739 | 94,884 | Apr 05, 2024, 04:30 PM |
Milnes Alistair | CHIEF OPERATING OFFICER | Apr 03, 2024 | Sale | $23.81 | 955 | 22,739 | 72,241 | Apr 05, 2024, 04:30 PM |
Crockett Nigel | CHIEF BUSINESS OFFICER | Apr 03, 2024 | Sale | $23.81 | 955 | 22,739 | 47,761 | Apr 05, 2024, 04:30 PM |
Keen Nicholas | CHIEF SCIENTIFIC OFFICER | Apr 03, 2024 | Sale | $23.81 | 790 | 18,810 | 62,803 | Apr 05, 2024, 04:30 PM |
Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Apr 03, 2024 | Sale | $23.81 | 152 | 3,619 | 23,223 | Apr 05, 2024, 04:30 PM |
Thompson Travis Alvin | Chief Accounting Officer | Jan 03, 2024 | Sale | $17.50 | 604 | 10,570 | 23,375 | Jan 04, 2024, 06:36 PM |
Keen Nicholas | Chief Scientific Officer | Jan 03, 2024 | Sale | $17.50 | 2,640 | 46,200 | 63,593 | Jan 04, 2024, 06:34 PM |
Crockett Nigel | Chief Business Officer | Jan 03, 2024 | Sale | $17.50 | 2,643 | 46,253 | 48,716 | Jan 04, 2024, 06:28 PM |
Milnes Alistair | Chief Operating Officer | Jan 03, 2024 | Sale | $17.50 | 2,643 | 46,253 | 73,196 | Jan 04, 2024, 06:27 PM |
Skynner Michael | Chief Technology Officer | Jan 03, 2024 | Sale | $17.50 | 2,643 | 46,253 | 95,839 | Jan 04, 2024, 06:26 PM |
Lee Kevin | Chief Executive Officer | Jan 03, 2024 | Sale | $17.50 | 8,703 | 152,303 | 390,428 | Jan 04, 2024, 06:25 PM |
Thompson Travis Alvin | Chief Accounting Officer | Oct 03, 2023 | Sale | $20.00 | 54 | 1,080 | 7,979 | Oct 05, 2023, 05:50 PM |
Keen Nicholas | Chief Scientific Officer | Oct 03, 2023 | Sale | $20.00 | 272 | 5,440 | 38,233 | Oct 05, 2023, 05:49 PM |
Crockett Nigel | Chief Business Officer | Oct 03, 2023 | Sale | $20.00 | 442 | 8,840 | 29,359 | Oct 05, 2023, 05:48 PM |
Milnes Alistair | Chief Operating Officer | Oct 03, 2023 | Sale | $20.00 | 442 | 8,840 | 36,839 | Oct 05, 2023, 05:47 PM |
Lee Kevin | Chief Executive Officer | Oct 03, 2023 | Sale | $20.00 | 1,470 | 29,400 | 322,131 | Oct 05, 2023, 05:46 PM |
Skynner Michael | Chief Technology Officer | Oct 03, 2023 | Sale | $20.00 | 442 | 8,840 | 70,482 | Oct 05, 2023, 05:46 PM |
Thompson Travis Alvin | Chief Accounting Officer | Jul 03, 2023 | Sale | $25.10 | 61 | 1,531 | 8,033 | Jul 06, 2023, 04:57 PM |
Skynner Michael | Chief Technology Officer | Jul 03, 2023 | Sale | $25.10 | 451 | 11,320 | 70,924 | Jul 06, 2023, 04:53 PM |
Milnes Alistair | Chief Operating Officer | Jul 03, 2023 | Sale | $25.10 | 451 | 11,320 | 37,281 | Jul 06, 2023, 04:52 PM |
Lee Kevin | Chief Executive Officer | Jul 03, 2023 | Sale | $25.10 | 1,498 | 37,600 | 323,601 | Jul 06, 2023, 04:51 PM |
Keen Nicholas | Chief Scientific Officer | Jul 03, 2023 | Sale | $25.10 | 336 | 8,434 | 38,505 | Jul 06, 2023, 04:50 PM |
Crockett Nigel | Chief Business Officer | Jul 03, 2023 | Sale | $25.10 | 451 | 11,320 | 29,801 | Jul 06, 2023, 04:49 PM |
Keen Nicholas | Chief Scientific Officer | Apr 03, 2023 | Sale | $21.11 | 319 | 6,734 | 38,841 | Apr 05, 2023, 04:43 PM |
Skynner Michael | Chief Technology Officer | Apr 03, 2023 | Sale | $21.11 | 447 | 9,436 | 71,375 | Apr 05, 2023, 04:43 PM |
Milnes Alistair | Chief Operating Officer | Apr 03, 2023 | Sale | $21.11 | 447 | 9,436 | 37,732 | Apr 05, 2023, 04:42 PM |
Kalowski Lee | President and CFO | Apr 03, 2023 | Sale | $21.11 | 376 | 7,937 | 30,309 | Apr 05, 2023, 04:41 PM |
Crockett Nigel | Chief Business Officer | Apr 03, 2023 | Sale | $21.11 | 447 | 9,436 | 30,252 | Apr 05, 2023, 04:40 PM |
Lee Kevin | Chief Executive Officer | Apr 03, 2023 | Sale | $21.11 | 1,486 | 31,369 | 325,099 | Apr 05, 2023, 04:39 PM |
Crockett Nigel | Chief Business Officer | Jan 03, 2023 | Sale | $29.06 | 1,801 | 52,337 | 30,699 | Jan 05, 2023, 09:21 PM |
Milnes Alistair | Chief Operating Officer | Jan 03, 2023 | Sale | $29.06 | 1,801 | 52,337 | 38,179 | Jan 05, 2023, 09:19 PM |
Smethurst Dominic | Chief Medical Officer | Jan 03, 2023 | Sale | $29.06 | 1,801 | 52,337 | 36,699 | Jan 05, 2023, 09:18 PM |
Skynner Michael | Chief Technology Officer | Jan 03, 2023 | Sale | $29.06 | 1,801 | 52,337 | 71,822 | Jan 05, 2023, 09:16 PM |
Keen Nicholas | Chief Scientific Officer | Jan 03, 2023 | Sale | $29.06 | 1,817 | 52,802 | 39,160 | Jan 05, 2023, 09:14 PM |
Kalowski Lee | President and CFO | Jan 03, 2023 | Sale | $29.06 | 1,815 | 52,744 | 30,685 | Jan 05, 2023, 09:12 PM |
Lee Kevin | Chief Executive Officer | Jan 03, 2023 | Sale | $29.06 | 6,000 | 174,360 | 326,585 | Jan 05, 2023, 09:06 PM |
Milnes Alistair | Chief Operating Officer | Mar 25, 2022 | Option Exercise | $20.12 | 5,155 | 103,719 | 22,480 | Mar 29, 2022, 04:36 PM |
Keen Nicholas | Chief Scientific Officer | Dec 21, 2021 | Option Exercise | $14.00 | 15,477 | 216,678 | 15,477 | Dec 22, 2021, 09:01 PM |
Legault Pierre | Director | Dec 20, 2021 | Option Exercise | $8.41 | 7,603 | 63,941 | 7,603 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 22, 2021 | Option Exercise | $8.48 | 97,860 | 829,853 | 97,860 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 21, 2021 | Option Exercise | $8.44 | 44,537 | 375,892 | 44,537 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 20, 2021 | Sale | $57.02 | 7,603 | 433,523 | 0 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 22, 2021 | Sale | $58.01 | 97,860 | 5,676,858 | 0 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 21, 2021 | Sale | $57.11 | 44,537 | 2,543,508 | 0 | Dec 22, 2021, 09:00 PM |
Lee Kevin | Chief Executive Officer | Oct 18, 2021 | Sale | $60.00 | 49 | 2,940 | 225,085 | Oct 18, 2021, 06:22 PM |
Lee Kevin | Chief Executive Officer | Oct 15, 2021 | Sale | $60.05 | 320 | 19,216 | 225,134 | Oct 18, 2021, 06:22 PM |
Lee Kevin | Chief Executive Officer | Oct 14, 2021 | Sale | $60.00 | 4,631 | 277,860 | 225,454 | Oct 18, 2021, 06:22 PM |
Lee Kevin | Chief Executive Officer | Oct 11, 2021 | Sale | $53.88 | 5,000 | 269,388 | 230,683 | Oct 13, 2021, 05:28 PM |
Keen Nicholas | Chief Scientific Officer | Oct 05, 2021 | Sale | $45.10 | 2,178 | 98,228 | 0 | Oct 05, 2021, 04:16 PM |
Keen Nicholas | Chief Scientific Officer | Oct 01, 2021 | Sale | $45.00 | 1,188 | 53,460 | 2,178 | Oct 05, 2021, 04:16 PM |
Smethurst Dominic | Chief Medical Officer | Sep 23, 2021 | Option Exercise | $18.55 | 6,000 | 111,300 | 6,000 | Sep 27, 2021, 04:53 PM |
Keen Nicholas | Chief Scientific Officer | Sep 16, 2021 | Sale | $45.01 | 1,955 | 87,995 | 3,366 | Sep 17, 2021, 04:47 PM |
Keen Nicholas | Chief Scientific Officer | Sep 15, 2021 | Sale | $45.00 | 3,000 | 135,000 | 5,321 | Sep 17, 2021, 04:47 PM |
Kalowski Lee | President and CFO | Sep 02, 2021 | Option Exercise | $9.82 | 10,000 | 98,200 | 10,000 | Sep 03, 2021, 04:49 PM |
Kalowski Lee | President and CFO | Sep 02, 2021 | Sale | $40.00 | 10,000 | 400,000 | 0 | Sep 03, 2021, 04:49 PM |
Keen Nicholas | Chief Scientific Officer | Sep 02, 2021 | Sale | $40.00 | 10,000 | 400,000 | 8,321 | Sep 03, 2021, 04:47 PM |
Lee Kevin | Chief Executive Officer | Sep 01, 2021 | Option Exercise | $14.00 | 22,890 | 320,460 | 267,170 | Sep 03, 2021, 04:46 PM |
Lee Kevin | Chief Executive Officer | Sep 02, 2021 | Sale | $40.00 | 5,000 | 200,000 | 235,085 | Sep 03, 2021, 04:46 PM |
Lee Kevin | Chief Executive Officer | Sep 01, 2021 | Sale | $37.21 | 27,085 | 1,007,897 | 258,979 | Sep 03, 2021, 04:46 PM |
Lee Kevin | Chief Executive Officer | Aug 31, 2021 | Option Exercise | $14.00 | 10,420 | 145,880 | 255,505 | Aug 31, 2021, 05:29 PM |
Lee Kevin | Chief Executive Officer | Aug 27, 2021 | Option Exercise | $14.00 | 1,808 | 25,312 | 246,893 | Aug 31, 2021, 05:29 PM |
Lee Kevin | Chief Executive Officer | Aug 27, 2021 | Sale | $36.02 | 1,808 | 65,124 | 245,085 | Aug 31, 2021, 05:29 PM |
Lee Kevin | Chief Executive Officer | Aug 31, 2021 | Sale | $36.33 | 11,225 | 407,763 | 245,552 | Aug 31, 2021, 05:29 PM |
Kalowski Lee | President and CFO | Aug 26, 2021 | Option Exercise | $8.76 | 550 | 4,818 | 550 | Aug 27, 2021, 06:31 PM |
Kalowski Lee | President and CFO | Aug 27, 2021 | Option Exercise | $8.73 | 7,950 | 69,403 | 7,950 | Aug 27, 2021, 06:31 PM |
Kalowski Lee | President and CFO | Aug 27, 2021 | Sale | $35.15 | 7,950 | 279,443 | 0 | Aug 27, 2021, 06:31 PM |
Kalowski Lee | President and CFO | Aug 26, 2021 | Sale | $35.04 | 550 | 19,272 | 0 | Aug 27, 2021, 06:31 PM |
Kalowski Lee | President and CFO | Aug 23, 2021 | Option Exercise | $1.60 | 7,500 | 12,000 | 7,500 | Aug 25, 2021, 05:45 PM |
Kalowski Lee | President and CFO | Aug 23, 2021 | Sale | $33.02 | 7,500 | 247,650 | 0 | Aug 25, 2021, 05:45 PM |
Kalowski Lee | President and CFO | Jul 29, 2021 | Option Exercise | $1.63 | 12,500 | 20,375 | 12,500 | Jul 30, 2021, 06:21 PM |
Kalowski Lee | President and CFO | Jul 29, 2021 | Sale | $31.51 | 12,500 | 393,823 | 3,504 | Jul 30, 2021, 06:21 PM |
Lee Kevin | Chief Executive Officer | Jul 23, 2021 | Option Exercise | $14.00 | 4,782 | 66,948 | 249,867 | Jul 27, 2021, 07:08 PM |
Lee Kevin | Chief Executive Officer | Jul 26, 2021 | Option Exercise | $14.00 | 100 | 1,400 | 245,185 | Jul 27, 2021, 07:08 PM |
Lee Kevin | Chief Executive Officer | Jul 23, 2021 | Sale | $36.02 | 4,782 | 172,248 | 245,085 | Jul 27, 2021, 07:08 PM |
Lee Kevin | Chief Executive Officer | Jul 26, 2021 | Sale | $36.00 | 100 | 3,600 | 245,085 | Jul 27, 2021, 07:08 PM |
BINGHAM KATE | Director | Jul 14, 2021 | Sale | $34.01 | 917 | 31,185 | 38,708 | Jul 20, 2021, 04:17 PM |
BINGHAM KATE | Director | Jul 13, 2021 | Sale | $33.50 | 12 | 402 | 39,625 | Jul 20, 2021, 04:17 PM |
BINGHAM KATE | Director | Jul 14, 2021 | Sale | $34.01 | 43,378 | 1,475,182 | 1,831,671 | Jul 20, 2021, 04:17 PM |
BINGHAM KATE | Director | Jul 13, 2021 | Sale | $33.50 | 588 | 19,698 | 1,875,049 | Jul 20, 2021, 04:17 PM |
Keen Nicholas | Chief Scientific Officer | Jul 14, 2021 | Sale | $35.00 | 10,000 | 350,000 | 18,321 | Jul 16, 2021, 06:27 PM |
Lee Kevin | Chief Executive Officer | Jul 16, 2021 | Option Exercise | $14.00 | 609 | 8,526 | 245,694 | Jul 16, 2021, 06:27 PM |
Lee Kevin | Chief Executive Officer | Jul 15, 2021 | Option Exercise | $14.00 | 21,970 | 307,580 | 267,055 | Jul 16, 2021, 06:27 PM |
Lee Kevin | Chief Executive Officer | Jul 16, 2021 | Sale | $34.00 | 609 | 20,706 | 245,085 | Jul 16, 2021, 06:27 PM |
Lee Kevin | Chief Executive Officer | Jul 15, 2021 | Sale | $34.28 | 21,970 | 753,132 | 245,085 | Jul 16, 2021, 06:27 PM |
BINGHAM KATE | Director | Jul 13, 2021 | Sale | $33.50 | 12 | 402 | 39,625 | Jul 15, 2021, 07:03 PM |
BINGHAM KATE | Director | Jul 14, 2021 | Sale | $34.01 | 43,378 | 1,475,182 | 1,831,671 | Jul 15, 2021, 07:03 PM |
BINGHAM KATE | Director | Jul 13, 2021 | Sale | $33.50 | 588 | 19,698 | 1,875,049 | Jul 15, 2021, 07:03 PM |
BINGHAM KATE | Director | Jul 14, 2021 | Sale | $34.01 | 917 | 31,185 | 38,708 | Jul 15, 2021, 07:03 PM |
Crockett Nigel | Chief Business Officer | Jul 13, 2021 | Option Exercise | $11.84 | 72,701 | 860,433 | 72,701 | Jul 14, 2021, 06:47 PM |
Crockett Nigel | Chief Business Officer | Jul 12, 2021 | Option Exercise | $11.72 | 7,028 | 82,380 | 7,028 | Jul 14, 2021, 06:47 PM |
Crockett Nigel | Chief Business Officer | Jul 13, 2021 | Sale | $32.44 | 72,701 | 2,358,362 | 3,121 | Jul 14, 2021, 06:47 PM |
Crockett Nigel | Chief Business Officer | Jul 12, 2021 | Sale | $32.03 | 7,028 | 225,107 | 0 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 14, 2021 | Option Exercise | $14.00 | 8,331 | 116,634 | 259,550 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 13, 2021 | Option Exercise | $14.00 | 35,446 | 496,244 | 290,180 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 12, 2021 | Option Exercise | $14.00 | 1,936 | 27,104 | 256,670 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 14, 2021 | Sale | $34.34 | 14,465 | 496,726 | 256,908 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 13, 2021 | Sale | $32.97 | 38,961 | 1,284,680 | 268,201 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 12, 2021 | Sale | $32.04 | 1,936 | 62,029 | 254,734 | Jul 14, 2021, 06:47 PM |
Crockett Nigel | Chief Business Officer | Jul 06, 2021 | Option Exercise | $9.82 | 271 | 2,661 | 271 | Jul 08, 2021, 05:22 PM |
Crockett Nigel | Chief Business Officer | Jul 06, 2021 | Sale | $32.00 | 271 | 8,672 | 0 | Jul 08, 2021, 05:22 PM |
Lee Kevin | Chief Executive Officer | May 07, 2021 | Option Exercise | $14.00 | 5,604 | 78,456 | 260,338 | May 10, 2021, 05:43 PM |
Lee Kevin | Chief Executive Officer | May 06, 2021 | Option Exercise | $14.00 | 1,716 | 24,024 | 256,450 | May 10, 2021, 05:43 PM |
Lee Kevin | Chief Executive Officer | May 07, 2021 | Sale | $32.23 | 5,604 | 180,617 | 254,734 | May 10, 2021, 05:43 PM |
Lee Kevin | Chief Executive Officer | May 06, 2021 | Sale | $32.14 | 1,716 | 55,152 | 254,734 | May 10, 2021, 05:43 PM |
Lee Kevin | Chief Executive Officer | Apr 27, 2021 | Option Exercise | $14.00 | 6,636 | 92,904 | 261,370 | Apr 28, 2021, 04:45 PM |
Lee Kevin | Chief Executive Officer | Apr 26, 2021 | Option Exercise | $14.00 | 14,545 | 203,630 | 273,345 | Apr 28, 2021, 04:45 PM |
Lee Kevin | Chief Executive Officer | Apr 26, 2021 | Sale | $31.28 | 18,611 | 582,144 | 268,630 | Apr 28, 2021, 04:45 PM |
Lee Kevin | Chief Executive Officer | Apr 27, 2021 | Sale | $30.70 | 6,636 | 203,728 | 255,092 | Apr 28, 2021, 04:45 PM |
Legault Pierre | Director | Apr 08, 2021 | Option Exercise | $8.74 | 24,838 | 217,084 | 24,838 | Apr 09, 2021, 04:36 PM |
Legault Pierre | Director | Apr 08, 2021 | Sale | $31.71 | 24,838 | 787,588 | 12,338 | Apr 09, 2021, 04:36 PM |
Legault Pierre | Director | Apr 05, 2021 | Option Exercise | $8.83 | 162 | 1,430 | 162 | Apr 07, 2021, 07:22 PM |
Legault Pierre | Director | Apr 05, 2021 | Sale | $31.07 | 162 | 5,033 | 0 | Apr 07, 2021, 07:22 PM |
Keen Nicholas | Chief Scientific Officer | Mar 31, 2021 | Sale | $30.00 | 10,000 | 300,000 | 28,321 | Apr 02, 2021, 04:45 PM |
Legault Pierre | Director | Mar 31, 2021 | Option Exercise | $8.78 | 10,000 | 87,800 | 10,000 | Apr 02, 2021, 04:44 PM |
Legault Pierre | Director | Mar 31, 2021 | Sale | $30.00 | 10,000 | 300,000 | 0 | Apr 02, 2021, 04:44 PM |
Legault Pierre | Director | Mar 17, 2021 | Option Exercise | $8.85 | 7,784 | 68,888 | 7,784 | Mar 19, 2021, 04:48 PM |
Legault Pierre | Director | Mar 17, 2021 | Sale | $29.00 | 7,784 | 225,736 | 0 | Mar 19, 2021, 04:48 PM |
Legault Pierre | Director | Mar 12, 2021 | Option Exercise | $8.86 | 2,216 | 19,634 | 2,216 | Mar 16, 2021, 07:42 PM |
Legault Pierre | Director | Mar 12, 2021 | Sale | $29.00 | 2,216 | 64,264 | 0 | Mar 16, 2021, 07:42 PM |
Keen Nicholas | Chief Scientific Officer | Mar 15, 2021 | Sale | $28.00 | 217 | 6,076 | 38,321 | Mar 16, 2021, 07:41 PM |
Keen Nicholas | Chief Scientific Officer | Mar 12, 2021 | Sale | $28.50 | 9,783 | 278,767 | 38,821 | Mar 16, 2021, 07:41 PM |
Lee Kevin | Chief Executive Officer | Feb 05, 2021 | Sale | $31.00 | 100 | 3,100 | 258,800 | Feb 09, 2021, 05:28 PM |
Lee Kevin | Chief Executive Officer | Jan 20, 2021 | Sale | $31.88 | 1,185 | 37,779 | 259,351 | Jan 21, 2021, 04:34 PM |
Lee Kevin | Chief Executive Officer | Jan 19, 2021 | Sale | $29.26 | 5,000 | 146,290 | 260,556 | Jan 21, 2021, 04:34 PM |
Kalowski Lee | President and CFO | Jan 19, 2021 | Option Exercise | $1.59 | 15,000 | 23,850 | 15,000 | Jan 21, 2021, 04:29 PM |
Kalowski Lee | President and CFO | Jan 19, 2021 | Sale | $30.00 | 15,000 | 450,000 | 0 | Jan 21, 2021, 04:29 PM |
Kalowski Lee | President and CFO | Jan 14, 2021 | Option Exercise | $1.60 | 10,000 | 16,000 | 10,000 | Jan 15, 2021, 04:44 PM |
Kalowski Lee | President and CFO | Jan 14, 2021 | Sale | $25.00 | 10,000 | 250,000 | 0 | Jan 15, 2021, 04:44 PM |
Lee Kevin | Chief Executive Officer | Jan 15, 2021 | Sale | $27.01 | 5,000 | 135,050 | 265,085 | Jan 15, 2021, 04:40 PM |
Lee Kevin | Chief Executive Officer | Jan 14, 2021 | Sale | $25.00 | 5,000 | 125,000 | 270,085 | Jan 15, 2021, 04:40 PM |
Kalowski Lee | President and CFO | Dec 01, 2020 | Option Exercise | $1.56 | 7,500 | 11,700 | 7,500 | Dec 03, 2020, 08:53 PM |
Kalowski Lee | President and CFO | Dec 01, 2020 | Sale | $22.50 | 7,500 | 168,750 | 0 | Dec 03, 2020, 08:53 PM |
Kalowski Lee | President and CFO | Nov 27, 2020 | Option Exercise | $1.56 | 530 | 827 | 530 | Nov 30, 2020, 04:42 PM |
Kalowski Lee | President and CFO | Nov 27, 2020 | Sale | $20.00 | 530 | 10,600 | 0 | Nov 30, 2020, 04:42 PM |
Kalowski Lee | President and CFO | Nov 23, 2020 | Option Exercise | $1.56 | 17,189 | 26,815 | 17,189 | Nov 25, 2020, 08:31 PM |
Kalowski Lee | President and CFO | Nov 25, 2020 | Option Exercise | $1.56 | 9,781 | 15,258 | 9,781 | Nov 25, 2020, 08:31 PM |
Kalowski Lee | President and CFO | Nov 25, 2020 | Sale | $20.07 | 9,781 | 196,305 | 0 | Nov 25, 2020, 08:31 PM |
Kalowski Lee | President and CFO | Nov 23, 2020 | Sale | $19.83 | 17,189 | 340,805 | 213 | Nov 25, 2020, 08:31 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Jul 15, 2020 | Sale | $19.40 | 3,147 | 61,045 | 1,910,609 | Sep 18, 2020, 12:04 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Jul 14, 2020 | Sale | $19.27 | 1,597 | 30,781 | 1,913,678 | Sep 18, 2020, 12:04 PM |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 10% Owner | May 28, 2019 | Buy | $14.00 | 364,286 | 5,100,004 | 1,957,961 | Jun 03, 2019, 05:15 PM |
Cambridge Innovation Capital (Jersey) Ltd | 10% Owner | May 29, 2019 | Buy | $14.00 | 314,286 | 4,400,004 | 1,751,437 | May 31, 2019, 05:12 PM |
Novartis Bioventures Ltd | 10% Owner | May 28, 2019 | Buy | $14.00 | 168,630 | 2,360,820 | 1,769,641 | May 30, 2019, 09:27 PM |
NG CAROLYN | Director | May 27, 2019 | Buy | $14.00 | 571,429 | 8,000,006 | 571,429 | May 30, 2019, 09:27 PM |
SVLSF V, LLC | 10% Owner | May 28, 2019 | Buy | $14.00 | 7,983 | 111,762 | 39,637 | May 30, 2019, 09:26 PM |
SVLSF V, LLC | 10% Owner | May 28, 2019 | Buy | $14.00 | 377,732 | 5,288,248 | 1,875,637 | May 30, 2019, 09:26 PM |
Anstey Michael | Director | May 28, 2019 | Buy | $14.00 | 314,286 | 4,400,004 | 1,751,437 | May 30, 2019, 09:26 PM |
BINGHAM KATE | Director | May 28, 2019 | Buy | $14.00 | 7,983 | 111,762 | 39,637 | May 30, 2019, 09:26 PM |
BINGHAM KATE | Director | May 28, 2019 | Buy | $14.00 | 377,732 | 5,288,248 | 1,875,637 | May 30, 2019, 09:26 PM |
HARLAND DEBORAH | Director | May 28, 2019 | Buy | $14.00 | 385,714 | 5,399,996 | 1,915,275 | May 30, 2019, 09:25 PM |
GLAXOSMITHKLINE PLC | Director | May 28, 2019 | Buy | $14.00 | 385,714 | 5,399,996 | 1,915,275 | May 30, 2019, 05:47 PM |
Owner | Relationship | Date | Value($) |
Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | 04/11/2024 | 5,780 |
Lee Kevin | CHIEF EXECUTIVE OFFICER | 04/03/2024 | 75,192 |
Skynner Michael | CHIEF TECHNOLOGY OFFICER | 04/03/2024 | 22,739 |
Milnes Alistair | CHIEF OPERATING OFFICER | 04/03/2024 | 22,739 |
Crockett Nigel | CHIEF BUSINESS OFFICER | 04/03/2024 | 22,739 |
Keen Nicholas | CHIEF SCIENTIFIC OFFICER | 04/03/2024 | 18,810 |
Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | 04/03/2024 | 3,619 |
Thompson Travis Alvin | Chief Accounting Officer | 01/03/2024 | 10,570 |
Keen Nicholas | Chief Scientific Officer | 01/03/2024 | 46,200 |
Crockett Nigel | Chief Business Officer | 01/03/2024 | 46,253 |
Milnes Alistair | Chief Operating Officer | 01/03/2024 | 46,253 |
Skynner Michael | Chief Technology Officer | 01/03/2024 | 46,253 |
Lee Kevin | Chief Executive Officer | 01/03/2024 | 152,303 |
Thompson Travis Alvin | Chief Accounting Officer | 10/03/2023 | 1,080 |
Keen Nicholas | Chief Scientific Officer | 10/03/2023 | 5,440 |
Crockett Nigel | Chief Business Officer | 10/03/2023 | 8,840 |
Milnes Alistair | Chief Operating Officer | 10/03/2023 | 8,840 |
Lee Kevin | Chief Executive Officer | 10/03/2023 | 29,400 |
Skynner Michael | Chief Technology Officer | 10/03/2023 | 8,840 |
Thompson Travis Alvin | Chief Accounting Officer | 07/03/2023 | 1,531 |
Skynner Michael | Chief Technology Officer | 07/03/2023 | 11,320 |
Milnes Alistair | Chief Operating Officer | 07/03/2023 | 11,320 |
Lee Kevin | Chief Executive Officer | 07/03/2023 | 37,600 |
Keen Nicholas | Chief Scientific Officer | 07/03/2023 | 8,434 |
Crockett Nigel | Chief Business Officer | 07/03/2023 | 11,320 |
Keen Nicholas | Chief Scientific Officer | 04/03/2023 | 6,734 |
Skynner Michael | Chief Technology Officer | 04/03/2023 | 9,436 |
Milnes Alistair | Chief Operating Officer | 04/03/2023 | 9,436 |
Kalowski Lee | President and CFO | 04/03/2023 | 7,937 |
Crockett Nigel | Chief Business Officer | 04/03/2023 | 9,436 |
Lee Kevin | Chief Executive Officer | 04/03/2023 | 31,369 |
Crockett Nigel | Chief Business Officer | 01/03/2023 | 52,337 |
Milnes Alistair | Chief Operating Officer | 01/03/2023 | 52,337 |
Smethurst Dominic | Chief Medical Officer | 01/03/2023 | 52,337 |
Skynner Michael | Chief Technology Officer | 01/03/2023 | 52,337 |
Keen Nicholas | Chief Scientific Officer | 01/03/2023 | 52,802 |
Kalowski Lee | President and CFO | 01/03/2023 | 52,744 |
Lee Kevin | Chief Executive Officer | 01/03/2023 | 174,360 |
Milnes Alistair | Chief Operating Officer | 03/25/2022 | 103,719 |
Keen Nicholas | Chief Scientific Officer | 12/21/2021 | 216,678 |
Legault Pierre | Director | 12/20/2021 | 63,941 |
Legault Pierre | Director | 12/22/2021 | 829,853 |
Legault Pierre | Director | 12/21/2021 | 375,892 |
Legault Pierre | Director | 12/20/2021 | 433,523 |
Legault Pierre | Director | 12/22/2021 | 5,676,858 |
Legault Pierre | Director | 12/21/2021 | 2,543,508 |
Lee Kevin | Chief Executive Officer | 10/18/2021 | 2,940 |
Lee Kevin | Chief Executive Officer | 10/15/2021 | 19,216 |
Lee Kevin | Chief Executive Officer | 10/14/2021 | 277,860 |
Lee Kevin | Chief Executive Officer | 10/11/2021 | 269,388 |
Keen Nicholas | Chief Scientific Officer | 10/05/2021 | 98,228 |
Keen Nicholas | Chief Scientific Officer | 10/01/2021 | 53,460 |
Smethurst Dominic | Chief Medical Officer | 09/23/2021 | 111,300 |
Keen Nicholas | Chief Scientific Officer | 09/16/2021 | 87,995 |
Keen Nicholas | Chief Scientific Officer | 09/15/2021 | 135,000 |
Kalowski Lee | President and CFO | 09/02/2021 | 98,200 |
Kalowski Lee | President and CFO | 09/02/2021 | 400,000 |
Keen Nicholas | Chief Scientific Officer | 09/02/2021 | 400,000 |
Lee Kevin | Chief Executive Officer | 09/01/2021 | 320,460 |
Lee Kevin | Chief Executive Officer | 09/02/2021 | 200,000 |
Lee Kevin | Chief Executive Officer | 09/01/2021 | 1,007,897 |
Lee Kevin | Chief Executive Officer | 08/31/2021 | 145,880 |
Lee Kevin | Chief Executive Officer | 08/27/2021 | 25,312 |
Lee Kevin | Chief Executive Officer | 08/27/2021 | 65,124 |
Lee Kevin | Chief Executive Officer | 08/31/2021 | 407,763 |
Kalowski Lee | President and CFO | 08/26/2021 | 4,818 |
Kalowski Lee | President and CFO | 08/27/2021 | 69,403 |
Kalowski Lee | President and CFO | 08/27/2021 | 279,443 |
Kalowski Lee | President and CFO | 08/26/2021 | 19,272 |
Kalowski Lee | President and CFO | 08/23/2021 | 12,000 |
Kalowski Lee | President and CFO | 08/23/2021 | 247,650 |
Kalowski Lee | President and CFO | 07/29/2021 | 20,375 |
Kalowski Lee | President and CFO | 07/29/2021 | 393,823 |
Lee Kevin | Chief Executive Officer | 07/23/2021 | 66,948 |
Lee Kevin | Chief Executive Officer | 07/26/2021 | 1,400 |
Lee Kevin | Chief Executive Officer | 07/23/2021 | 172,248 |
Lee Kevin | Chief Executive Officer | 07/26/2021 | 3,600 |
BINGHAM KATE | Director | 07/14/2021 | 31,185 |
BINGHAM KATE | Director | 07/13/2021 | 402 |
BINGHAM KATE | Director | 07/14/2021 | 1,475,182 |
BINGHAM KATE | Director | 07/13/2021 | 19,698 |
Keen Nicholas | Chief Scientific Officer | 07/14/2021 | 350,000 |
Lee Kevin | Chief Executive Officer | 07/16/2021 | 8,526 |
Lee Kevin | Chief Executive Officer | 07/15/2021 | 307,580 |
Lee Kevin | Chief Executive Officer | 07/16/2021 | 20,706 |
Lee Kevin | Chief Executive Officer | 07/15/2021 | 753,132 |
BINGHAM KATE | Director | 07/13/2021 | 402 |
BINGHAM KATE | Director | 07/14/2021 | 1,475,182 |
BINGHAM KATE | Director | 07/13/2021 | 19,698 |
BINGHAM KATE | Director | 07/14/2021 | 31,185 |
Crockett Nigel | Chief Business Officer | 07/13/2021 | 860,433 |
Crockett Nigel | Chief Business Officer | 07/12/2021 | 82,380 |
Crockett Nigel | Chief Business Officer | 07/13/2021 | 2,358,362 |
Crockett Nigel | Chief Business Officer | 07/12/2021 | 225,107 |
Lee Kevin | Chief Executive Officer | 07/14/2021 | 116,634 |
Lee Kevin | Chief Executive Officer | 07/13/2021 | 496,244 |
Lee Kevin | Chief Executive Officer | 07/12/2021 | 27,104 |
Lee Kevin | Chief Executive Officer | 07/14/2021 | 496,726 |
Lee Kevin | Chief Executive Officer | 07/13/2021 | 1,284,680 |
Lee Kevin | Chief Executive Officer | 07/12/2021 | 62,029 |
Crockett Nigel | Chief Business Officer | 07/06/2021 | 2,661 |
Crockett Nigel | Chief Business Officer | 07/06/2021 | 8,672 |
Lee Kevin | Chief Executive Officer | 05/07/2021 | 78,456 |
Lee Kevin | Chief Executive Officer | 05/06/2021 | 24,024 |
Lee Kevin | Chief Executive Officer | 05/07/2021 | 180,617 |
Lee Kevin | Chief Executive Officer | 05/06/2021 | 55,152 |
Lee Kevin | Chief Executive Officer | 04/27/2021 | 92,904 |
Lee Kevin | Chief Executive Officer | 04/26/2021 | 203,630 |
Lee Kevin | Chief Executive Officer | 04/26/2021 | 582,144 |
Lee Kevin | Chief Executive Officer | 04/27/2021 | 203,728 |
Legault Pierre | Director | 04/08/2021 | 217,084 |
Legault Pierre | Director | 04/08/2021 | 787,588 |
Legault Pierre | Director | 04/05/2021 | 1,430 |
Legault Pierre | Director | 04/05/2021 | 5,033 |
Keen Nicholas | Chief Scientific Officer | 03/31/2021 | 300,000 |
Legault Pierre | Director | 03/31/2021 | 87,800 |
Legault Pierre | Director | 03/31/2021 | 300,000 |
Legault Pierre | Director | 03/17/2021 | 68,888 |
Legault Pierre | Director | 03/17/2021 | 225,736 |
Legault Pierre | Director | 03/12/2021 | 19,634 |
Legault Pierre | Director | 03/12/2021 | 64,264 |
Keen Nicholas | Chief Scientific Officer | 03/15/2021 | 6,076 |
Keen Nicholas | Chief Scientific Officer | 03/12/2021 | 278,767 |
Lee Kevin | Chief Executive Officer | 02/05/2021 | 3,100 |
Lee Kevin | Chief Executive Officer | 01/20/2021 | 37,779 |
Lee Kevin | Chief Executive Officer | 01/19/2021 | 146,290 |
Kalowski Lee | President and CFO | 01/19/2021 | 23,850 |
Kalowski Lee | President and CFO | 01/19/2021 | 450,000 |
Kalowski Lee | President and CFO | 01/14/2021 | 16,000 |
Kalowski Lee | President and CFO | 01/14/2021 | 250,000 |
Lee Kevin | Chief Executive Officer | 01/15/2021 | 135,050 |
Lee Kevin | Chief Executive Officer | 01/14/2021 | 125,000 |
Kalowski Lee | President and CFO | 12/01/2020 | 11,700 |
Kalowski Lee | President and CFO | 12/01/2020 | 168,750 |
Kalowski Lee | President and CFO | 11/27/2020 | 827 |
Kalowski Lee | President and CFO | 11/27/2020 | 10,600 |
Kalowski Lee | President and CFO | 11/23/2020 | 26,815 |
Kalowski Lee | President and CFO | 11/25/2020 | 15,258 |
Kalowski Lee | President and CFO | 11/25/2020 | 196,305 |
Kalowski Lee | President and CFO | 11/23/2020 | 340,805 |
GLAXOSMITHKLINE PLC | 10% Owner | 07/15/2020 | 61,045 |
GLAXOSMITHKLINE PLC | 10% Owner | 07/14/2020 | 30,781 |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 10% Owner | 05/28/2019 | 5,100,004 |
Cambridge Innovation Capital (Jersey) Ltd | 10% Owner | 05/29/2019 | 4,400,004 |
Novartis Bioventures Ltd | 10% Owner | 05/28/2019 | 2,360,820 |
NG CAROLYN | Director | 05/27/2019 | 8,000,006 |
SVLSF V, LLC | 10% Owner | 05/28/2019 | 111,762 |
SVLSF V, LLC | 10% Owner | 05/28/2019 | 5,288,248 |
Anstey Michael | Director | 05/28/2019 | 4,400,004 |
BINGHAM KATE | Director | 05/28/2019 | 111,762 |
BINGHAM KATE | Director | 05/28/2019 | 5,288,248 |
HARLAND DEBORAH | Director | 05/28/2019 | 5,399,996 |
GLAXOSMITHKLINE PLC | Director | 05/28/2019 | 5,399,996 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BAKER BROS. ADVISORS LP | 7,689,243 | 2.11% | 55.56% | Other |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,545,026 | 6.58% | -6.38% | Growth, Growth At A Reasonable Price |
SUVRETTA CAPITAL MANAGEMENT, LLC | 914,476 | 0.85% | No change | Growth At A Reasonable Price |
CANDRIAM S.C.A. | 889,258 | 0.14% | 2.3% | Other |
RA CAPITAL MANAGEMENT, L.P. | 800,000 | 0.26% | No change | Other |
BLACKROCK INC. | 575,030 | 0.00033% | 14.63% | Other |
PLATINUM INVESTMENT MANAGEMENT LTD | 333,001 | 0.33% | -8.03% | Growth At A Reasonable Price, Value |
DUQUESNE FAMILY OFFICE LLC | 190,200 | 0.11% | New | Other |
RENAISSANCE TECHNOLOGIES LLC | 165,700 | 0.00649% | 57.06% | Other |
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 70,000 (Call) | 0.00926% | -44% | Value |
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 84,980 | 0.15% | 15.46% | Value |
GEODE CAPITAL MANAGEMENT, LLC | 21,377 | 0.00005% | 13.48% | Other |
Period of Report: 03/31/2024
10-K/10-Q Filings: View